Status:
COMPLETED
Patient-Centric Innovation: Superior Vena Cava Approach in Zero-Fluoroscopy
Lead Sponsor:
Ning Zhou
Conditions:
Atrioventricular Nodal Reentrant Tachycardia
Eligibility:
All Genders
18+ years
Brief Summary
This study aims to evaluate the viability and therapeutic efficacy of zero-fluoroscopy radiofrequency catheter ablation (RFCA) using the superior vena cava (SVC) approach in patients with atrioventric...
Detailed Description
This retrospective study investigates the feasibility and therapeutic efficacy of zero-fluoroscopy radiofrequency catheter ablation (RFCA) using the superior vena cava (SVC) approach in patients diagn...
Eligibility Criteria
Inclusion
- Adults aged \>18 years.
- Diagnosed with atrioventricular nodal reentrant tachycardia (AVNRT).
- Underwent radiofrequency catheter ablation (RFCA) at our institution between June 2022 and October 2022.
- Experienced at least one episode of AVNRT during transesophageal atrial pacing (TEAP) and programmed stimulation.
- Provided informed consent for the procedure and data collection.
Exclusion
- AVNRT attributed to reversible causes, such as acute myocarditis or recent cardiac surgery.
- Presence of other types of tachycardias (e.g., atrial tachycardia, Wolff-Parkinson-White syndrome, ventricular tachycardia).
- Inability to abstain from pharmacological interventions for at least five half-lives of the medication prior to TEAP.
- Contraindications for the use of conscious sedation or local anesthesia.
- Severe comorbidities that would interfere with study participation or follow-up.
- Patients who are pregnant or lactating.
- Previous RFCA procedures for AVNRT within the past six months.
Key Trial Info
Start Date :
October 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 20 2024
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT06492499
Start Date
October 1 2022
End Date
June 20 2024
Last Update
July 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China, 430030